MedPath
HSA Approval

PAXIDORM TABLETS 25 mg

SIN10851P

PAXIDORM TABLETS 25 mg

PAXIDORM TABLETS 25 mg

April 1, 1999

POLYMEDIC TRADING ENTERPRISE PTE LTD

POLYMEDIC TRADING ENTERPRISE PTE LTD

Regulatory Information

HSA regulatory responsibility and product classification details

Regulatory Responsibility

RegistrantPOLYMEDIC TRADING ENTERPRISE PTE LTD
Licence HolderPOLYMEDIC TRADING ENTERPRISE PTE LTD

Product Classification

D
Drug Type
Therapeutic
F
Forensic Class
Pharmacy Only
HSA Singapore Classification

Formulation Information

TABLET, SUGAR COATED

ORAL

Medical Information

R06AA02

diphenhydramine

Manufacturer Information

POLYMEDIC TRADING ENTERPRISE PTE LTD

PHARMASERVE LTD

Active Ingredients

DIPHENHYDRAMINE HCl

25 mg

Diphenhydramine

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.

PAXIDORM TABLETS 25 mg - HSA Approval | MedPath